Is HH Biotechnology Holdings Co halal to invest in?

According to Musaffa's Shariah screening methodology, HH Biotechnology Holdings Co (HHBT) is currently classified as NOT COVERED as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is HH Biotechnology Holdings Co a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes HH Biotechnology Holdings Co using these criteria to determine its compliance status.

Can Muslims buy shares of HH Biotechnology Holdings Co?

Muslim investors may consider investing in HH Biotechnology Holdings Co if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is HH Biotechnology Holdings Co classified as NOT COVERED?

Musaffa determines the Shariah status of HH Biotechnology Holdings Co by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for HH Biotechnology Holdings Co updated?

The Shariah compliance status of HH Biotechnology Holdings Co may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like HH Biotechnology Holdings Co become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of HH Biotechnology Holdings Co?

You can check the latest Shariah compliance status of HH Biotechnology Holdings Co on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

HH Biotechnology Holdings Co. Stock Analysis HHBT

United States Real Estate Nano Cap

HH Biotechnology Holdings Co. through its various subsidiaries, is engaged in the commercial and residential real estate leasing, management, consulting, investment, development and sales in the city of Shenyang, Liaoning Province, in the People' Republic of China. The company is headquartered in Shenyang, Liaoning. The company went IPO on 2012-07-23. The firm operates through two segments. The Property for Sale segment is primarily engaged in real estate sales. The Rental Income and Income of Management Fee of Commercial Buildings segment is primarily engaged in rental income and management fee income of commercial buildings. The firm conducts all operations through its direct and indirect subsidiaries, which include Shenyang Maryland International Industry Company Limited and Silverstrand International Holdings Company Limited. The firm is focused primarily on real estate leasing, management and consulting activities in the city of Shenyang.

Key Statistics of HH Biotechnology Holdings Co (HHBT)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

7589.00

P/E Ratio (TTM)

0.00

52 Week Range

$0.00$0.00

Market Cap

1400.00

Avg. Volume

8355.00

Dividend Yield

Financial Metrics & Statements of HH Biotechnology Holdings Co (HHBT)

FAQ's for HH Biotechnology Holdings Co (HHBT)

According to Musaffa’s Shariah screening methodology, HH Biotechnology Holdings Co (HHBT) is currently classified as NOT COVERED as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.